Enter your login e-mail to the account
Search
- Preventive physical examination of cancer survivors at general practitioner’s office
MUDr. Soňa Huľová, PhD.
(3/2025, General Medicine ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Precision neuro-oncology: reality and perspectives
Ing. et Ing. Jiří Polívka, Ph.D., MSc. Rashmi Negi, MUDr. Richard Koleják, MUDr. Jiří Polívka, CSc., MUDr. Pavel Potužník, Ph.D.
(5/2023, Main topic ) - Kmenové buňky: Současný stav laboratorního výzkumu a perspektivy léčby míšního poranění
MUDr. Tomáš Soukup1, MUDr. Jana Karbanová1, doc. MUDr. Jaroslav Mokrý, Ph.D., MUDr. Petr Suchomel, Ph.D.
(2/2005, Main topic ) - Laboratory biomarkers – neural antibodies in autoimmune diseases of the central nervous system
MUDr. Hana Mojžišová, MUDr. Martin Elišák, Ph.D., Prof. MUDr. Petr Marusič, Ph.D.
(3/2023, Main topic )
- One morning, when Gregor Samsa woke from troubled dreams
MUDr. Veronika Vestenická, PhD.
(2/2017 ) - A rare cause of extreme hypotrophy in newborns
MUDr. Marie Kasíková, MUDr. Alice Mocková, Ph.D.
(1/2026, Original articles and Case reports )
- Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - New approaches in the testing of HER2 status in the biopsies of breast carcinoma patients
prof. MUDr. Lukáš Plank, CSc.
(2/2024, Review articles ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Personalized medicine approach in metastatatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(6/2013, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Adjuvant therapy of colorectal cancer in elderly patients
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(4/2007, Review articles ) - Antibody-drug conjugates (ADCs): a revolution in the treatment of metastatic breast cancer?
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2025, Main topic ) - External radiotherapy of the most common primary brain tumors
MUDr. Karol Martinka
(5/2024, Review articles ) - Ocular graft-versus-host disease and its treatment options
MUDr. Barbora Žiaková, MUDr. Eva Bojtárová, PhD.
(5/2024, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Biological treatment with monoclonal antibody
MUDr. Andrey Švec, PhD., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(2/2019, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Latent tuberculosis – risk factors of tuberculosis
MUDr. Jana Malinová, MUDr. Marta Hájková, CSc., MUDr. Antónia Hatalová, PhD., doc. MUDr. Emőke Šteňová, PhD.
(2/2019, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(4/2025, Information & comments ) - Treatment options in EGFR-mutated non-small cell lung cancer
MUDr. Marcela Vojčiaková, MUDr. Branislav Bystrický, PhD., MPH, MUDr. Filip Kohútek, PhD., MUDr. Júlia Vidulin, MUDr. Zuzana Miklátková
(1/2026, Review articles ) - Contemporary possibilities of adrenocortical carcinoma treatment
doc. MUDr. Ján Ľupták, PhD., prof. MUDr. Ján Kliment, CSc., MUDr. Boris Eliáš, PhD., prof. MUDr. Ján Švihra, PhD., MUDr. Ján Kliment jr.
(1/2013, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Bratislavské onkologické dni, LVIII. ročník – odborný program a abstrakty
Kolektív autorov
(S2/2021, Abstracts ) - Bratislavské onkologické dni, LVII. ročník – odborný program a abstrakty
Kolektív autorov
(S3/2020, Abstracts ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Metastatic colorectal cancer – results of treatment of the primary tumor localization
MUDr. Vanda Ušáková, PhD.
(2/2017, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Targeted diagnosis of endometrial cancer
doc. MUDr. Karol Kajo, PhD., MUDr. Peter Šuran, MUDr. Katarína Macháleková, PhD., Mgr. Lenka Kalinková, PhD., RNDr. Ivana Fridrichová, CSc.
(5/2020, Main topic ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Relevance of the PI3K signaling pathway in advanced breast cancer and the possibilities of targeted treatment
MUDr. Bela Mriňáková, PhD., MPH
(5/2020, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(4/2022, Information & comments ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - Anti-EGFR treatment in colorectal cancer – what is ist role today and in the future?
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(5/2019, Review articles ) - Novinky z ASCO 2023, 15. ročník
MUDr. Mária Rečková, PhD.
(4/2023, Events ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - Publikujeme v zahraničí
Kolektív autorov
(3/2020, Information & comments ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Etiopathogenesis of cervical cancer
MUDr. Oliver Sadovský, CSc., prof. RNDr. Ján Vojtaššák, CSc.
(5/2010, Review articles ) - Antibody-drug conjugates and bispecific T-cell engagers in the treatment of advanced lung cancer
MUDr. Filip Kohútek, PhD., MUDr. Júlia Vidulin, MUDr. Branislav Bystrický, PhD., MPH
(4/2026, Main topic ) - Ras genes of metastatic colorectal carcinoma
RNDr. Katarína Hlinková
(4/2014, Review articles ) - State of the art and treatment perspectives of penile cancer
Doc. MUDr. Katarína Rejleková, PhD.
(3/2024, Main topic ) - Antibody-drug conjugates in the treatment of breast cancer
MUDr. Miroslava Malejčíková
(4/2026, Main topic ) - The combination of cetuximab and radiotherapy in the first line treatment of colorectal carcinoma – The Slovak project
MUDr. Tomáš Šálek, MUDr. Marián Streško, MUDr. Jozef Chovanec, MUDr. Eduard Šebo, MUDr. Dagmar Mazalová, MUDr. Alena Thomková, a ďalší
(5/2010, Original articles & case reports ) - Bratislavské onkologické dni, LX. ročník – odborný program a abstrakty
Kolektív autorov
(S1/2023, Abstracts ) - Antibody-drug conjugates in the treatment of advanced gynaecological malignancies
MUDr. Róbert Biel, PhD., MBA
(4/2026, Main topic ) - Effectivity of reduced dose of afatinib in patient with metastatic del 19 adenocarcinoma
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal
(3/2020, Case reports ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - How to treat colorectal cancer in the context of new knowledge of new molecular markers
MUDr. Tomáš Šálek, MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Zuzana Mináriková, PhD., MUDr. Eva Zomborská, MUDr. Ján Slopovský, MUDr. Benjamin Špánik
(3/2021, Review articles ) - Visceral crisis in metastatic breast cancer
MUDr. Emília Fatkulinová
(4/2026, Review articles ) - Why do some lung cancer patients receive no anticancer treatment?
doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma
MUDr. Radovan Barila, PhD.
(3/2021, Drugs & drug classes ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Bratislavské onkologické dni LIX. ročník
Kolektív autorov
(S4/2022, Abstracts ) - Bratislavské onkologické dni LVI. ročník
Kolektív autorov
(S3/2019, Abstracts ) - Uterine serous carcinoma
MUDr. Lucia Kocová, MUDr. Tibor Lengyel, PhD., MPH
(2/2025, Main topic ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - A comprehensive view of the treatment of HER2-positive breast cancer
MUDr. Bela Mriňáková, PhD., MPH
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Everolimus in treatment of HR-positive/HER2-negative breast cancer – clinical experience
MUDr. Oľga Szegheőová
(2/2025, Drugs & drug classes ) - Trastuzumab deruxtecan – drug profile and use in the treatment of advanced HER2-positive breast cancer
MUDr. Radovan Barila, PhD., MUDr. Lenka Svobodová, MUDr. Ján Bujňák, PhD.
(2/2022, Drugs & drug classes ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Non-metastatic triple-negative breast cancer – biological properties and current management
Prof. MUDr. Erik Kúdela, PhD., MBA, MUDr. Eva Kúdelová, PhD.
(6/2024, Review articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - 9TH TH WORLD CONGRESS ON GASTROINTESTINAL CANCER, 27. – 30. JÚN 2008, BARCELONA
MUDr. Tomáš Šálek
(3/2008, Events ) - Molecular biology of colorectal cancer from the perspective of the pathologist
MUDr. Michal Kalman
(5/2014, Main topic ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Newer MR techniques in the diagnosis of solid tumors
MUDr. Lýdia Frigová
(2/2020, Review articles ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Publikujeme v zahraničí
(4/2016, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?
MUDr. Miroslava Malejčíková
(2/2023, Review articles ) - Current therapeutic options for advanced and metastatic biliary tract cancer
MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Natália Pazderová, MUDr. Benjamin Špánik, MUDr. Štefan Pörsök, PhD., MPH
(5/2025, Main topic ) - Optimization of treatment of colorectal cancer
MUDr. Iveta Andrezálová Vochyanová
(5/2015, Review articles ) - Combination of targeted therapy and immunotherapy: benefits, limits and open questions across diagnoses
MUDr. Filip Kohútek, PhD., MUDr. Júlia Vidulin, MUDr. Branislav Bystrický, PhD., MPH
(5/2025, Review articles ) - Efficacy and cardiotoxicity risk of adjuvant treatment in HER2-positive patients with breast cancer
MUDr. Jaroslava Lešková
(1/2020, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(1/2020, Information & comments ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Publikujeme v zahraničí
Kolektív autorov
(5/2023, Information & comments ) - The role of osimertinib in the treatment of lung cancer
MUDr. Anna Kollárová
(1/2024, Drugs & drug classes ) - Trends in the treatment of HPV+ oropharyngeal cancer in Slovakia
MUDr. Michaela Švajdová, PhD.
(6/2025, Original articles ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2024, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Neoadjuvant therapy of triple-negative breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(4/2020, Review articles ) - Chemotherapy in combination with radiotherapy in locally advanced head and neck carcinoma
doc. MUDr. Pavol Dubinský, PhD.
(2/2015, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Personalization of treatment of colorectal cancer in 1st line
MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Ján Slopovský, MUDr. Tomáš Šálek
(4/2020, Main topic ) - Optimal first-line treatment of mCRC
MUDr. Jana Ďurková
(1/2017, Review articles ) - ERBITUX®: cielená blokáda egfr zvyšuje účinnosť liečby
MUDr. Lenka Slanináková
(1/2006, Review articles ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Treatment of BRAF wt metastatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(4/2021, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(1/2025, Information & comments ) - INTERNATIONAL MEETING ON INNOVATIVE APPROACHES IN HEAD AND NECK ONCOLOGY,BARCELONA 2007
MUDr. Tibor Barta, PhD.
(3/2007, Events ) - CLEAR CELL OVARIAN CANCOR – A CASE STORY
doc. MUDr. Lýdia Heľpianska, CSc., MUDr. Ivana Krajčovičová
(2/2006, Original articles ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2009, Information & comments ) - News in the treatment of lung tumors in the elderly
MUDr. Zuzana Pribulová
(6/2023, Main topic ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - COMPLETE REMISION AFTER CETUXIMAB WITH IRINOTECAN IN COMBINATION WITH SURGICAL TREATMENT IN PRETREATED PATIENT (CASE REPORT)
MUDr. Jozef Šufliarsky
(3/2007, Original articles ) - Current trends in the diagnosis and management of urothelial carcinoma
MUDr. Zuzana Országhová, PhD.
(3/2026, Main topic )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Progress in the biological treatment of psoriasis
Prof. MUDr. Mária Šimaljaková, PhD
(1/2018, Drugs & drug classes ) - The most common adverse effects of oncological treatment on the skin of patients
MUDr. Katarína Trenčanská
(3/2026, Review articles ) - Healing of wounds with hyaluronic acid
MUDr. Katarína Poláková, PhD.
(1/2012, Review articles ) - Ki-67 antigen and p53 protein expression in basal cell carcinoma of the skin – a topic review
MUDr. Milada Kullová, MUDr. Vladimír Bartoš, PhD.
(2-3/2013, Review articles ) - Advers skin effect of target therapy in oncology
MUDr. Katarína Poláková, PhD.
(4/2018, Review articles ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )
- CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly )
- Brain metastases in solid tumours
doc. MUDr. Peter Beržinec, CSc.
(1/2012, Review articles ) - Targeted biologic therapies and related side effects in most common cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2009, Review articles )
- Healing of wounds with hyaluronic acid
MUDr. Katarína Poláková, PhD.
(4/2011, Current pharmacotherapy )
- Spectrum of pathogenic variants in the NOTCH3 gene in patients with CADASIL syndrome
RNDr. Miriama Juhosová, PhD., doc. MUDr. Ján Chandoga, CSc.,, RNDr. Robert Petrovič, PhD.
(1/2024, Main topic ) - Contemporary approaches to genetic diagnostics in clinical oncology
RNDr. Regína Lohajová Behulová, PhD., Mgr. Michal Svoboda, RNDr. Aster Alemayehu, PhD., Mgr. Lukáš Šebest, PhD.
(2/2024, Main topic )